Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8832 |
High Similarity |
NPD3027 |
Phase 3 |
0.8662 |
High Similarity |
NPD7228 |
Approved |
0.8571 |
High Similarity |
NPD6234 |
Discontinued |
0.8511 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8511 |
High Similarity |
NPD1613 |
Approved |
0.8487 |
Intermediate Similarity |
NPD37 |
Approved |
0.8442 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8442 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8442 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8288 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8286 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8227 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8116 |
Intermediate Similarity |
NPD3705 |
Approved |
0.811 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8086 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8037 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7847 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7791 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7755 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7673 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7655 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.758 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7556 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7552 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2977 |
Approved |
0.75 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7445 |
Intermediate Similarity |
NPD228 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7324 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7317 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7315 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7301 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7299 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7209 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7195 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7186 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7039 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7032 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7013 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7012 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.6987 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.698 |
Remote Similarity |
NPD8651 |
Approved |
0.6978 |
Remote Similarity |
NPD2684 |
Approved |
0.6975 |
Remote Similarity |
NPD1512 |
Approved |
0.6974 |
Remote Similarity |
NPD7095 |
Approved |
0.6968 |
Remote Similarity |
NPD6653 |
Approved |
0.6957 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6948 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6941 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6933 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6928 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD7906 |
Approved |
0.6923 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD27 |
Approved |
0.6919 |
Remote Similarity |
NPD2489 |
Approved |
0.6914 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6913 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6906 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD3657 |
Discovery |
0.6893 |
Remote Similarity |
NPD7313 |
Approved |
0.6893 |
Remote Similarity |
NPD7312 |
Approved |
0.6893 |
Remote Similarity |
NPD8312 |
Approved |
0.6893 |
Remote Similarity |
NPD7311 |
Approved |
0.6893 |
Remote Similarity |
NPD7310 |
Approved |
0.6893 |
Remote Similarity |
NPD8313 |
Approved |
0.6889 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD7819 |
Suspended |
0.6886 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD5773 |
Approved |
0.6886 |
Remote Similarity |
NPD5772 |
Approved |
0.6886 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD7466 |
Approved |
0.6875 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD6671 |
Approved |
0.6872 |
Remote Similarity |
NPD4663 |
Approved |
0.6867 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD5604 |
Discontinued |
0.686 |
Remote Similarity |
NPD2970 |
Approved |
0.686 |
Remote Similarity |
NPD2969 |
Approved |
0.6854 |
Remote Similarity |
NPD8054 |
Approved |
0.6854 |
Remote Similarity |
NPD7309 |
Approved |
0.6854 |
Remote Similarity |
NPD8053 |
Approved |
0.6852 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6839 |
Remote Similarity |
NPD4140 |
Approved |
0.6833 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.681 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6802 |
Remote Similarity |
NPD3051 |
Approved |
0.6802 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6802 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.68 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6798 |
Remote Similarity |
NPD4578 |
Approved |
0.6798 |
Remote Similarity |
NPD4577 |
Approved |
0.6792 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6788
|
Remote Similarity |
NPD7827 |
Phase 1 |